EMA Authorised: Imuldosa (ustekinumab) — Accord Healthcare S.L.U.

View source ↗

Summary

The European Medicines Agency authorised Imuldosa (ustekinumab) from Accord Healthcare S.L.U. for Crohn's disease, psoriasis, and psoriatic arthritis. The decis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• IMULDOSA (ustekinumab-srlf)

Snippet

Status: Authorised. Therapeutic area: Crohn Disease;Psoriasis;Arthritis, Psoriatic. MAH: Accord Healthcare S.L.U.. Decision date: 15/01/2026